You are viewing the site in preview mode

Skip to main content

Table 3 Toxicities by grade of severity, according to the CTCAE (version 4.03)

From: Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomas

Chemotherapy-related toxicity n (%)
Toxicity Grade 1 Grade 2 Grade 3 Grade 4
Hypertension 6 (35.3) 2 (11.8)
Proteinuria 7 (41.2) 2 (11.8) 1 (5.9)
Thromboembolic event 1 (5.9)
Headache 4 (23.5)
Skin alteration 3 (17.6)
Hypotension 2 (11.8)
Thrombocytopenia 1 (5.9) 1 (5.9)
Leukopenia 2 (11.8) 4 (23.5)
Anemia 3 (17.6)
Hypertransaminasemia 5 (29.4)
Astenia 1 (5.9) 3 (17.6)